Genistein could bind to and inhibit mitogen-activated protein kinase kinase 4 (MEK4) kinase activity in prostate cancer cells, which in turn attenuated matrix metalloproteinase-2 (MMP-2) expression and reduced cell invasion [45]. Here, MAPK4 is linked to prostate carcinoma.